Weight Management

Weight is complicated.
You are capable.

The science of weight regulation is genuinely complex — involving genetics, hormones, stress, sleep, environment, and more. This page covers what the evidence actually says, without shame, without judgment, and without selling you anything.

Start Here View Diet Evidence
Factors that influence body weight
Genetics & epigenetics
Hormones (leptin, insulin, ghrelin)
Stress & cortisol
Sleep quality & duration
Gut microbiome composition
Food environment & access
Medications
Willpower alone
Section 1

Obesity — A disease, not a character flaw

In 2013, the American Medical Association formally recognized obesity as a complex, chronic disease. This wasn't a redefinition for convenience — it reflected decades of evidence about the biological, neurological, and genetic drivers of body weight.

🏛️
Official recognition
The AMA (2013), WHO, CDC, and American Academy of Pediatrics all classify obesity as a chronic, multifactorial disease. The Obesity Medicine Association describes it as "a chronic, relapsing, multifactorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical, and psychosocial health consequences."
🧬
Not a personal failure
Research consistently shows that body weight is regulated by powerful biological systems — the same way blood pressure or thyroid function is regulated. These systems don't yield to willpower any more than a malfunctioning pancreas yields to determination. Treating obesity as a moral or motivational failure is not just inaccurate — it actively harms people by discouraging them from seeking appropriate care.
⚖️
BMI — useful but limited
BMI (Body Mass Index = weight ÷ height²) is the most common classification tool but has important limitations. It doesn't distinguish fat from muscle, doesn't account for fat distribution (visceral vs. subcutaneous), and has documented racial and sex-based biases. A muscular athlete and someone with metabolic disease may have the same BMI. Waist circumference, waist-to-hip ratio, and metabolic markers provide a more complete picture.
BMI Classification (WHO)
ClassificationBMI RangeHealth context
Underweight< 18.5Associated with nutritional deficiency, immune risk, bone loss
Normal weight18.5 – 24.9Lowest statistical disease risk in large populations
Overweight25.0 – 29.9Modestly elevated risk; metabolic health varies widely
Obesity Class I30.0 – 34.9Increased risk of Type 2 diabetes, cardiovascular disease
Obesity Class II35.0 – 39.9High risk; most medical interventions become appropriate
Obesity Class III≥ 40.0Very high risk; significantly impairs quality of life and longevity
⚠️ BMI is a population screening tool — it does not diagnose disease in individuals and should always be interpreted alongside metabolic labs, waist circumference, and clinical context.
💬
The weight stigma problem

Weight stigma — the social devaluation of people because of their weight — is one of the last socially accepted forms of discrimination. Research published in Obesity Reviews shows that weight stigma in healthcare settings causes patients to avoid care, delay screenings, and experience worse outcomes. Providers who attribute unrelated complaints to weight (a phenomenon called "diagnostic overshadowing") miss diagnoses and erode trust. Stigma doesn't motivate change — it causes harm.

Section 2

The science of weight — Why it varies so much between people

Two people can eat the same foods, exercise the same amount, and end up at very different body weights. This isn't a mystery — it's biology. Here are the key systems at play.

01
Genetics
Twin studies show that 40–70% of BMI variation is heritable. Over 900 genetic variants associated with BMI have been identified. Genes influence appetite regulation, fat storage patterns, basal metabolic rate, how you respond to exercise, and where fat is deposited. You can't choose your genetic starting point.
40–70% of BMI variation is genetic
02
Epigenetics
Your genes aren't destiny — but how they're expressed can be shaped by experiences before and after birth. Maternal nutrition during pregnancy, early childhood food environment, stress exposure, and even your grandparents' diet can alter gene expression in ways that affect your metabolism. Epigenetic changes can be passed across generations.
Maternal diet affects fetal metabolic programming
03
Leptin & Ghrelin
Leptin is produced by fat cells and signals fullness to the brain. In obesity, leptin resistance often develops — the brain stops hearing the signal, leaving the hunger system permanently activated. Ghrelin, the "hunger hormone," rises when you lose weight and stays elevated for months to years — your body defending against weight loss as if it were starvation.
Ghrelin stays elevated for 1+ years after weight loss
04
Insulin & Blood Sugar
Insulin manages glucose storage — but chronically elevated insulin (from ultra-processed diets, sleep deprivation, or insulin resistance) signals the body to store fat and blocks fat burning. Insulin resistance creates a vicious cycle: higher insulin → more fat storage → more insulin resistance → harder to lose weight. This is a metabolic disease, not a discipline problem.
Insulin resistance affects ~88% of American adults
05
Cortisol & Stress
Chronic stress elevates cortisol, which directly promotes visceral fat deposition (especially abdominal fat), increases appetite for calorie-dense foods, disrupts sleep, and impairs glucose regulation. People living in chronically stressful environments — financial insecurity, unsafe neighborhoods, demanding jobs — face biological headwinds that have nothing to do with motivation.
Chronic stress increases visceral fat independently of diet
06
Sleep
Even one night of poor sleep measurably increases ghrelin, decreases leptin, and shifts food preference toward high-calorie, high-carbohydrate foods. People sleeping less than 6 hours per night have significantly higher rates of obesity than those sleeping 7–9 hours. Sleep deprivation is an independent driver of weight gain — not a symptom of it.
<6 hrs sleep = 55% higher obesity risk (adults)
07
Gut Microbiome
Landmark research from the Weizmann Institute shows that two people eating identical foods can have dramatically different blood glucose responses based on their gut microbiome. Certain bacterial profiles extract more calories from food, alter appetite hormones (including GLP-1 and PYY), and affect fat storage. Microbiome composition is influenced by diet, antibiotic use, birth method, and early environment.
Same food → up to 4× different glucose spike by person
08
Medications & Medical Conditions
Dozens of commonly prescribed medications cause clinically significant weight gain: antidepressants, antipsychotics, beta-blockers, corticosteroids, insulin, and some diabetes medications. Hypothyroidism, PCOS, Cushing's syndrome, and other conditions impair weight regulation. Always review medications and rule out underlying conditions before attributing weight changes to behavior alone.
Antidepressants: avg +5–10 lb weight gain over 1 year
The bottom line on weight and biology

Weight is regulated by an extraordinarily complex system. When that system is dysregulated — by disease, genetics, stress, sleep deprivation, or environmental factors — behavioral interventions alone are rarely sufficient. This doesn't mean behavior doesn't matter. It means that framing obesity as purely a willpower problem is scientifically incorrect — and harmful to the people living with it.

Section 3

The Set Point — Why your body fights weight loss

Losing weight is hard. Keeping it off is harder. And each time you lose and regain, the next attempt often becomes more difficult. This isn't weakness — it's biology defending itself.

What is the weight set point?

Your body has a "defended weight" — a range it actively works to maintain through hormonal, neurological, and metabolic mechanisms. When weight drops below this range, the body responds with increased hunger, reduced resting metabolism, decreased non-exercise movement (fidgeting, posture, spontaneous activity), and altered hormones — all working to push weight back up. This system evolved to protect against famine. In an environment of caloric abundance, it works against us.

80%
of lost weight is regained within 5 years in typical diet studies
−15–30%
reduction in resting metabolism after significant weight loss (adaptive thermogenesis)
6 yr+
duration that hunger hormones remain elevated after weight loss in research studies
Why each weight-loss attempt gets harder
1
Adaptive thermogenesis
When you lose weight through caloric restriction, your body reduces its resting metabolic rate beyond what's explained by the smaller body mass alone. A landmark study of Biggest Loser contestants found their metabolism remained suppressed 6 years after the show — burning ~500 fewer calories per day than expected — even as their weight rebounded. The "slowdown" is real and persistent.
2
Muscle loss accelerates the problem
Caloric restriction without adequate protein and resistance training causes significant muscle loss alongside fat loss. Muscle tissue burns more calories at rest than fat tissue. Each round of "diet, regain" tends to replace lost muscle with fat — called "body composition drift." Over multiple cycles, your body becomes less metabolically active, making the same caloric deficit less effective than it was before.
3
Hormonal "memory"
Ghrelin (hunger) and leptin (fullness) don't return to pre-diet levels after weight is regained — they reset to a new imbalance that favors higher weight. The longer this hormonal environment persists, the more your brain recalibrates its defended weight upward. This is why starting a third or fourth diet often feels harder than the first: the hormonal resistance has compounded.
4
The Minnesota Starvation Study
In 1944–45, 36 healthy, normal-weight conscientious objectors were put on a 1,570 kcal/day diet (significant restriction for active men). They became obsessed with food, irritable, socially withdrawn, and depressed. Their resting metabolism dropped 40%. When normal eating resumed, they binged compulsively for months and ended up heavier than before. Restriction triggers powerful, involuntary biological responses that look like "failure" but are survival physiology.
💡
What this means practically

The goal shouldn't be "lose as much weight as fast as possible." Research increasingly supports modest, sustained weight loss (5–10% of body weight) achieved through lifestyle changes the person can actually maintain — rather than aggressive restriction that triggers metabolic adaptation and rebound. Even small, sustained losses dramatically improve metabolic markers, blood pressure, blood sugar, and joint health. This is also why medications like GLP-1 agonists work: they address the hormonal environment, not just the behavior.

Section 4

The diet landscape — What the evidence actually shows

There are hundreds of named diets. Most share one trait: they work better in studies than in real life, and better in the short term than the long term. Here's an honest look at the most common approaches.

Strong evidence Moderate evidence Weak / limited evidence Concern or risk
Mediterranean Diet
Strong evidence
Emphasizes vegetables, fruits, whole grains, legumes, fish, olive oil, and nuts. Moderate wine. Limited red meat and processed foods.
What research shows
The PREDIMED trial (7,447 participants) found Mediterranean diet reduced major cardiovascular events by ~30% vs. low-fat diet. Strong evidence for long-term adherence, mortality reduction, cognitive protection, and metabolic improvement. The most studied dietary pattern with the most consistently positive outcomes across populations.
Practical Flexible, socially sustainable, no elimination. Can be adapted across cultures. Most providers and dietitians recommend this as a foundation.
Plant-Based / Whole Food
Strong evidence
Emphasizes vegetables, fruits, whole grains, legumes, nuts, and seeds. Reduces or eliminates animal products. Focuses on food quality over restriction.
What research shows
Consistently associated with lower BMI, reduced cardiovascular disease, Type 2 diabetes prevention, and improved longevity. The Adventist Health Study and EPIC-Oxford study found plant-based diets produce significantly lower BMI across populations. High fiber content supports satiety, gut microbiome diversity, and metabolic health. Most large population studies on longevity show plant-dominant diets, not exclusively plant diets, have the strongest outcomes.
Practical Requires attention to protein sources, B12, and iron. When well-planned, highly sustainable long-term. Overlaps significantly with Mediterranean diet principles.
Ketogenic / Very Low Carb
Moderate evidence
Severe carbohydrate restriction (<50g/day) forces the body into ketosis — burning fat for fuel instead of glucose. High fat, moderate protein.
What research shows
Short-term (6–12 months): effective for weight loss, often faster initial loss than low-fat diets due to water loss and appetite suppression. Clear benefit for Type 2 diabetes management and epilepsy (strong evidence). Long-term: adherence is poor, and benefits largely equalize with other diets at 12–24 months. Raises LDL in some people. Insufficient evidence for long-term cardiovascular safety.
Practical Hard to sustain socially. Carbohydrate restriction causes significant initial side effects ("keto flu"). Many people cycle in and out, negating long-term benefits.
Atkins Diet
Moderate evidence
A phased low-carbohydrate approach starting with very low carb (20g/day) and gradually reintroducing carbohydrates over time. Preceded the keto movement by decades.
What research shows
Short-term outcomes similar to keto. A Stanford A-TO-Z trial found Atkins produced slightly more weight loss at 12 months than low-fat, Zone, and Ornish diets — but differences disappeared at 24 months. Primary mechanism is appetite suppression from ketosis and protein satiety. Long-term adherence studies show similar drop-off to other restrictive diets.
Practical The induction phase is restrictive and difficult. Many people don't progress through the phases as designed, getting stuck in long-term severe restriction.
Intermittent Fasting
Moderate evidence
Cycling between eating and fasting periods. Common protocols: 16:8 (eat within 8 hours), 5:2 (normal eating 5 days, 500–600 cal 2 days), alternate day fasting.
What research shows
A 2022 NEJM review found IF produces comparable weight loss to continuous calorie restriction — not superior. The primary mechanism is calorie reduction via restricted eating windows, not metabolic magic. Some evidence for metabolic benefits independent of weight loss. Early time-restricted eating (eating earlier in the day, finishing by 3–6pm) shows stronger metabolic signals than later windows. A 2023 JAMA trial found 16:8 not superior to calorie counting alone.
Practical Works well for people who prefer not to count calories. Social challenges around meal times. Not appropriate for people with eating disorder history, pregnancy, or certain medical conditions.
Low-Fat / Calorie Counting
Moderate evidence
Traditional dietary guidance: reduce fat, count calories, create a deficit. Standard recommendation for decades.
What research shows
Works when followed — which is the problem. Calorie counting is cognitively demanding, emotionally taxing, and poorly sustainable long-term. Low-fat diets often replaced fat with refined carbohydrates, worsening metabolic outcomes. The Women's Health Initiative trial (49,000 women, 8 years) found low-fat diet produced minimal weight loss and no cardiovascular benefit vs. control. The "calories in, calories out" model is technically correct but practically incomplete — it ignores the hormonal and behavioral drivers that regulate both sides of the equation.
Practical Most people abandon calorie counting within months. It fosters an unhealthy relationship with food and ignores food quality entirely.
Carnivore Diet
Weak / limited evidence
Animal products only — meat, fish, eggs, some dairy. Complete elimination of plants, grains, legumes, and vegetables.
What research shows
No randomized controlled trials of meaningful size or duration exist. The existing evidence is case reports and self-reported surveys (Shawn Baker, 2021). Some report initial weight loss and inflammation reduction, likely due to eliminating processed foods and allergens. The elimination of all plant fiber is a serious concern — gut microbiome diversity collapses, and fiber is the primary fuel for beneficial gut bacteria. Long-term cardiovascular and microbiome outcomes are unknown.
Concern Eliminating all plant foods removes the only dietary source of fiber, phytonutrients, and prebiotic compounds. This is a major departure from all dietary patterns associated with longevity. Not recommended as a long-term strategy by mainstream nutrition science.
Fad Diets — Why they fail
Not recommended
Juice cleanses No evidence of "detoxification" — your liver and kidneys handle that. Extreme calorie restriction followed by rebound.
Detox teas & drops No controlled trials. Often contain laxatives or diuretics causing water weight loss, not fat loss.
Meal replacement shakes Very low calorie diets (<800 kcal) trigger aggressive adaptive thermogenesis. Weight regain is nearly universal.
Elimination diets (gluten-free, dairy-free without diagnosis) No benefit for weight loss in people without documented intolerance or celiac disease.
Any diet sold as "effortless" or "secret" Weight regulation is complex and requires genuine sustained change. If a program promises otherwise, it's marketing, not medicine.
What all fad diets share
They create short-term caloric restriction through rigid rules. They work while you're following them perfectly and fail when life intervenes — which it always does. They don't address the hormonal, psychological, and environmental drivers of eating behavior. And they often leave people feeling like they failed, when in reality the diet failed them.
"Can I do this for the rest of my life?"

This is the most important question you can ask about any dietary change. Not "will this produce fast results?" or "does this feel manageable for 30 days?" — but "could I genuinely sustain this pattern for the next 20 years, through holidays, travel, stress, celebrations, illness, and aging?"

Likely sustainable
  • Eating more vegetables at every meal
  • Switching to whole grains most of the time
  • Cooking at home 4–5 nights a week
  • Reducing ultra-processed food frequency
  • Eating breakfast with protein
  • Stopping eating when satisfied, not stuffed
Rarely sustainable long-term
  • Counting every calorie every day forever
  • Eliminating entire food groups permanently
  • Never eating at restaurants or social meals
  • Preparing special meals separate from family
  • Feeling deprived at every meal
  • Rigid rules with no flexibility for real life
Section 5

Eat more, not less — The volume eating principle

Restriction triggers your biology to fight back. The more effective strategy is adding nourishing, high-volume foods that crowd out calorie-dense options — not white-knuckling hunger.

The Restriction Cycle
Cut calories severely
↓
Hunger hormones surge
↓
Metabolism slows
↓
Cravings intensify
↓
Diet breaks down
↓
Weight rebounds above start
VS
The Addition Approach
Add vegetables to every meal
↓
Higher fiber = more satiety
↓
Less room for processed food
↓
Stable blood sugar, less craving
↓
Pattern sustains naturally
↓
Gradual body composition shift
Calorie density vs. food volume

The key insight: you eat a similar volume of food each day regardless of calorie content. Research by Barbara Rolls (Penn State, "Volumetrics") shows that people consume roughly the same weight of food per day. If that food is calorie-dense (chips, pastries, fried foods), total calories are high. If it's high in water and fiber (vegetables, fruits, soups, salads), total calories are dramatically lower — while the same physical fullness is achieved.

High calorie density
Small volume, many calories
Potato chips (1 oz)152 kcal
Cheese (1 oz)115 kcal
Candy bar (1 bar, ~1.5 oz)210 kcal
Croissant (1 medium)272 kcal
Peanut butter (2 tbsp)188 kcal
Low calorie density
Large volume, fewer calories
Strawberries (1 cup)49 kcal
Broccoli (1 cup)31 kcal
Cucumber (1 cup)16 kcal
Lentil soup (1 cup)230 kcal
Watermelon (2 cups)85 kcal
The swap principle
Same fullness, fewer calories
½ cup white rice→½ cup rice + ½ cup cauliflower rice
Chips as snack→Veggies + hummus
Pasta with butter→Pasta + zucchini + sauce
Juice with breakfast→Whole fruit (same sugar, triple the fiber)
What to add, not what to take away
🥗
A vegetable at every meal. Not a side dish — a significant portion. Aim for half the plate at lunch and dinner.
🫘
Legumes 3–4 times a week. Beans, lentils, and chickpeas are the highest-satiety, highest-fiber foods available at any price point.
🥣
Protein at breakfast. Protein in the morning reduces total daily caloric intake by stabilizing appetite hormones through the afternoon.
💧
Water before meals. Drinking 16 oz of water 30 minutes before eating reduced caloric intake by ~13% in one RCT — simply by increasing stomach volume.
🌾
Whole grains instead of refined. Same meals, dramatically more fiber. Oats instead of cornflakes. Brown rice instead of white. The swap is small; the satiety difference is significant.
🍎
Whole fruit instead of juice. The same sugars, but with fiber that slows absorption, keeps you full, and feeds your gut microbiome. Never drink your calories if you can eat them instead.
Section 6

Sustainable change — What actually works long-term

The evidence on long-term weight management consistently points away from dramatic interventions and toward a different question: not "how do I lose weight fast?" but "how do I build a life where my body naturally settles at a healthier place?"

🏗️
Build the environment, not just the willpower
Research on successful long-term weight maintainers (the National Weight Control Registry, 10,000+ people) shows they structure their environment: they keep trigger foods out of the house, cook at home regularly, weigh themselves consistently, eat breakfast, and limit TV time. They don't rely on motivation — they build systems. Environment shapes behavior more reliably than resolve.
📊
Non-scale victories matter more than the number
Body weight fluctuates 2–5 lbs daily based on hydration, sodium, hormonal cycles, and bowel movements. Tracking only the scale causes unnecessary discouragement. Track what actually reflects health: energy levels, sleep quality, blood pressure, blood sugar, cholesterol, clothing fit, how far you can walk, mood, and inflammation markers. These often improve significantly before the scale moves much.
🤝
Address the psychological relationship with food
Emotional eating, binge-restrict cycles, food as comfort or punishment, and shame around eating are extraordinarily common — and undertreated. Evidence-based approaches including Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), and mindful eating have strong trial support for improving eating behavior independent of specific dietary content. Psychology is part of nutrition medicine, not separate from it.
💪
Muscle is your metabolic engine
Resistance training 2–3 times per week preserves and builds muscle mass — the primary driver of resting metabolism. Unlike cardio alone (which the body adapts to efficiently), resistance training consistently increases the calories burned at rest. People who maintain weight loss long-term are significantly more likely to include strength training. Muscle doesn't just look better — it metabolically protects against weight regain.
😴
Sleep and stress are not optional
No dietary pattern overcomes chronic sleep deprivation or unmanaged stress. Both directly alter appetite hormones, metabolic rate, and food choice. Treating sleep as a health priority — 7–9 hours, consistent schedule, limiting screens — and developing stress regulation skills (therapy, exercise, nature, social connection) are non-negotiable components of a weight management plan that actually works.
🩺
When to consider medical intervention
For people with Class II or III obesity, or Class I with metabolic comorbidities, lifestyle intervention alone has a poor long-term success rate — not because of personal failure, but because of the biological mechanisms described throughout this page. GLP-1 medications, bariatric surgery, and medically supervised programs are legitimate, evidence-based treatments for a legitimate disease. Seeking medical help for obesity is no different from seeking it for hypertension. It is appropriate and often necessary.
A note on compassion — toward yourself and others

If you've struggled with your weight for years, tried multiple approaches, and feel like you keep failing — please understand that the research overwhelmingly supports your experience. The biological system regulating body weight is powerful, persistent, and largely outside voluntary control. You are not weak. You have been fighting a system that was designed to resist exactly what you're trying to do.

The path forward isn't another stricter diet. It's building the most nourishing, sustainable, enjoyable relationship with food you can — understanding your biology rather than fighting it, seeking appropriate medical support when needed, and measuring success in health and wellbeing, not just the number on a scale.

— Created by a board-certified Physician Associate
Medication Reference

Weight Management Medications — A Clinical Comparison

A reference guide to medications commonly used for weight loss and metabolic health. Some are FDA-approved specifically for obesity; others are approved for diabetes and used off-label. This is educational information — medication decisions require individualized evaluation with your provider.

Weight Loss Approved Diabetes Approved Off-Label Use Rx Only OTC Available
Medication
Brand / Generic		 Form & Dose FDA Indication & Off-Label Expected
Weight Loss		 Common Side Effects Contraindications Est. Monthly Cost
💊 Oral Medications — Older / Established
Glucophage
Metformin
DiabetesOff-LabelRx Only
 Oral tablet (IR or ER)
500–2,000 mg/day
Taken with food		 FDA: Type 2 diabetes
Off-label: Prediabetes, PCOS, modest weight loss in insulin-resistant patients		 2–3%
~2–5 lbs over 1–2 yrs		 Nausea, diarrhea, GI upset (usually transient); B12 deficiency with long-term use; lactic acidosis (rare) eGFR <30 mL/min; liver disease; excessive alcohol; metabolic acidosis; hold before IV contrast ~$4–20
generic Rx
Xenical / Alli
Orlistat
Weight LossRx (Xenical)OTC (Alli)
 Oral capsule
Xenical: 120 mg 3×/day
Alli (OTC): 60 mg 3×/day
Take with each fat-containing meal		 FDA: Weight management and maintenance (Xenical); weight loss aid (Alli OTC)
Off-label: N/A		 3–5%
~5–7 lbs vs placebo at 1 yr		 Oily/fatty stools, oily spotting, fecal urgency, flatulence with discharge, fecal incontinence; GI effects worsen with high-fat meals; fat-soluble vitamin malabsorption (A, D, E, K) — supplement required Malabsorption syndromes; cholestasis; pregnancy; caution with warfarin, cyclosporine, thyroid medications, antiepileptics Xenical: ~$500–700
Alli: ~$40–60
OTC
Adipex-P / Lomaira
Phentermine
Weight LossSchedule IV
 Oral capsule/tablet/ODT
15–37.5 mg/day
Lomaira: 8 mg 3×/day
Take in AM; avoid PM		 FDA: Short-term (≤12 weeks) adjunct weight management
Off-label: Longer-term use (common); combined with topiramate		 3–5%
~5–10 lbs vs placebo short-term		 Dry mouth, insomnia, elevated heart rate and BP, palpitations, restlessness, constipation; potential for tolerance and dependence; mood changes Cardiovascular disease; uncontrolled hypertension; hyperthyroidism; glaucoma; history of drug abuse; MAOIs (within 14 days); pregnancy; agitation/anxiety disorders ~$30–75
generic Rx
Topamax / Trokendi XR
Topiramate
Off-LabelRx Only
 Oral tablet / ER capsule
25–200 mg/day
Start low; titrate slowly over weeks		 FDA: Epilepsy; migraine prevention
Off-label: Weight loss; binge eating disorder; alcohol use disorder		 5–7%
Dose-dependent; most effective combined with phentermine (Qsymia)		 Cognitive impairment ("Dopamax" — word-finding, memory, concentration), paresthesia (tingling), kidney stones, metabolic acidosis, taste changes, hair loss; acute glaucoma (rare but serious — stop immediately) Pregnancy (teratogen — cleft palate risk); kidney stones; metabolic acidosis; hypersensitivity; monitor serum bicarbonate; caution with carbonic anhydrase inhibitors ~$15–45
generic Rx
Wellbutrin SR/XL
Bupropion
Off-LabelRx Only
 Oral tablet (IR, SR, XL)
150–450 mg/day
Titrate up; avoid cutting XL		 FDA: Major depression; seasonal affective disorder; smoking cessation (as Zyban)
Off-label: Weight loss; ADHD		 3–5%
~5–10 lbs; reduces appetite and cravings		 Dry mouth, insomnia, headache, nausea, elevated BP, anxiety, irritability; dose-dependent seizure risk; Blackbox: suicidality in patients <25 Seizure disorder; eating disorders (bulimia/anorexia — seizure risk); MAOIs within 14 days; abrupt alcohol or benzodiazepine withdrawal; pregnancy (relative) ~$15–40
generic Rx
💊 Oral Combination Medications — FDA-Approved for Obesity
Contrave
Naltrexone / Bupropion ER
Weight LossRx Only
 Oral ER tablet
Target: naltrexone 32 mg + bupropion 360 mg/day
Titrate over 4 weeks (2 tabs BID)		 FDA (2014): Chronic weight management — adults with BMI ≥30, or ≥27 with ≥1 weight-related comorbidity
Off-label: N/A		 5–9%
COR trials: ~4–5 lbs vs placebo at 1 yr		 Nausea (~32%, most common), constipation, headache, vomiting, dizziness, insomnia, dry mouth; blocks opioid effects; Blackbox: suicidality (bupropion component) Current opioid use or dependence (blocks opioids — precipitates withdrawal); seizure disorder; uncontrolled hypertension; eating disorders; MAOIs; pregnancy; cannot combine with opioid pain medications ~$200–400
some insurance coverage
Qsymia
Phentermine / Topiramate ER
Weight LossREMS Program
 Oral ER capsule
Start: 3.75/23 mg × 2 wks → 7.5/46 mg (recommended) → max 15/92 mg
Take AM; REMS: monthly pregnancy test required		 FDA (2012): Chronic weight management — BMI ≥30, or ≥27 with comorbidity; REMS program required for women of childbearing potential
Off-label: N/A		 7–10%
CONQUER: 7.8% (recommended dose); ~10% (max dose) vs ~1.4% placebo		 Paresthesia/tingling, dry mouth, constipation, insomnia, elevated HR, cognitive effects (topiramate component — word-finding, concentration), taste changes, metabolic acidosis Pregnancy — teratogen (cleft palate risk from topiramate); negative pregnancy test + contraception required; glaucoma; hyperthyroidism; MAOIs; cardiovascular disease; history of drug abuse (phentermine component) ~$130–200
GoodRx; brand higher
💉💊 GLP-1 Receptor Agonists — Injectable & Oral (Peptide-Based)
Saxenda
Liraglutide 3 mg
Weight LossRx OnlyDaily Injection
 Subcutaneous injection — daily
Start 0.6 mg/day; weekly titration to 3 mg/day
(Victoza = lower dose for T2D)		 FDA: Chronic weight management adults (2014); obesity in adolescents 12+ (2020)
Related: Victoza (liraglutide 1.2–1.8 mg) FDA-approved for T2D and CV risk reduction		 5–8%
SCALE: 8.4% vs 2.8% placebo; ~62% achieved ≥5% loss		 Nausea (very common, ~40%), vomiting, diarrhea, constipation, decreased appetite, injection site reactions, increased heart rate, headache; Blackbox: thyroid C-cell tumors (rodent data) Personal or family history of medullary thyroid carcinoma (MTC) or MEN type 2; pregnancy; severe GI disease; prior pancreatitis (caution); gallbladder disease (caution) ~$1,349 list
Generic liraglutide: ~$1,165
No active NovoCare self-pay program; patient assistance available for qualifying low-income patients
Ozempic
Semaglutide (0.5–2 mg)
DiabetesOff-Label Wt.Rx OnlyWeekly Injection
 Subcutaneous injection — weekly
Start 0.25 mg × 4 wks → 0.5 mg; max 2 mg/wk
Rybelsus = oral tablet (T2D only)		 FDA: Type 2 diabetes; CV risk reduction in T2D with CVD; CKD risk reduction in T2D (2023)
Off-label: Weight loss (very widely used — not the FDA-approved weight dose)		 5–10%
At T2D doses (off-label for weight); less than Wegovy's 2.4 mg dose		 Nausea, vomiting, diarrhea, abdominal pain, constipation, decreased appetite, injection site reactions; same class warnings as all GLP-1 agents; Blackbox: thyroid C-cell tumors Personal or family history of MTC or MEN type 2; pregnancy; severe GI disease; history of pancreatitis (caution); prior hypersensitivity to semaglutide NovoCare self-pay:
$349/mo (0.25–1 mg)
$499/mo (2 mg dose)
~$1,000+ list; introductory $199/mo for new patients on starter doses (offer ends 3/31/26). Check novocare.com for current terms.
Wegovy (injection)
Semaglutide 2.4 mg
Weight LossRx OnlyWeekly Injection
 Subcutaneous injection — weekly
Start 0.25 mg; titrate over 16–20 wks to 2.4 mg/wk
Same molecule as Ozempic — higher dose		 FDA (2021): Chronic weight management — adults BMI ≥30, or ≥27 with comorbidity
FDA (2022): Obesity in adolescents 12+
FDA (2024): CV risk reduction in obesity/overweight with established CVD (SELECT trial — first weight med with this indication)		 ~15%
STEP 1: 14.9% vs 2.4% placebo; ~32% achieved ≥20% loss		 Nausea (very common), vomiting, diarrhea, constipation, abdominal pain, headache, fatigue; muscle mass loss possible (ensure adequate protein + resistance exercise); Blackbox: thyroid C-cell tumors Personal or family history of MTC or MEN type 2; pregnancy; severe GI disease; pancreatitis (caution); prior hypersensitivity to semaglutide; gallbladder disease (caution — cholelithiasis risk) NovoCare self-pay:
$349/mo (standard)
~$1,349 list; introductory $199/mo for new patients (offer ends 3/31/26). Insurance coverage improving post-SELECT trial. Check novocare.com for current terms.
Wegovy (tablet)
Oral Semaglutide 25 mg
Weight LossRx OnlyDaily Oral
 Oral tablet — once daily
Titrate: 1.5 mg → 4 mg → 9 mg → 25 mg (maintenance)
Take on empty stomach with water; do not cut/crush; wait 30 min before eating		 FDA (Dec 2025): Chronic weight management in adults — BMI ≥30, or ≥27 with ≥1 comorbidity
First and only oral GLP-1 approved for weight loss. Distinct from Rybelsus, which is a lower-dose oral semaglutide approved only for T2D.		 ~15%
OASIS trials (50 mg): −15.1% vs −2.4% placebo; OASIS 4 (25 mg, pivotal): ~14–17%; ~76% achieved ≥5% loss		 Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite; generally similar GI profile to injectable; must be taken correctly (fasting, with plain water) or absorption is significantly reduced; Blackbox: thyroid C-cell tumors Personal or family history of MTC or MEN type 2; pregnancy; severe GI disease; pancreatitis (caution); prior hypersensitivity to semaglutide; avoid with other semaglutide products (Ozempic, Wegovy injection, Rybelsus) NovoCare self-pay:
$149/mo (1.5 mg & 4 mg starters)
$299/mo (9 mg & 25 mg maintenance)
~$1,349 list. Check novocare.com — starter dose pricing changes after 4/15/26.
💊 Oral GLP-1 Receptor Agonist — Small Molecule (Non-Peptide)
Foundayo
Orforglipron
Weight LossRx OnlyDaily Oral
 Oral tablet — once daily
Titrate: 0.8 mg → 2.5 mg → 5.5 mg → 9 mg → 14.5 mg → 17.2 mg (maintenance)
No food or water restrictions — take any time of day; no fasting window required		 FDA (Apr 1, 2026): Chronic weight management in adults — BMI ≥30, or ≥27 with ≥1 weight-related comorbidity
First and only non-peptide (small molecule) oral GLP-1 agonist. Unlike oral semaglutide (Wegovy tablet), no fasting or water restrictions — meaningfully different pharmacology. Approved under FDA's National Priority Voucher program in 50 days — fastest new molecular entity approval since 2002.		 ~11–12%
ATTAIN-1 (week 72): −12.4% (27.3 lbs) at highest dose vs −0.9% placebo (completers); −11.1% vs −2.1% (ITT). ATTAIN-2 (T2D): up to −9.6% vs −2.5% placebo. ACHIEVE-3 head-to-head vs oral semaglutide: orforglipron 19.7 lbs lost vs semaglutide 11.3 lbs.		 Nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, fatigue, belching, heartburn, gas, hair loss; GI side effects generally similar to peptide GLP-1s; Blackbox: thyroid C-cell tumors (rodent data — class warning for all GLP-1 receptor agonists) Personal or family history of medullary thyroid carcinoma (MTC) or MEN type 2; serious hypersensitivity to orforglipron; pregnancy (use effective contraception) LillyDirect self-pay:
$149/mo (lowest dose)
Commercial insurance savings card: as low as $25/mo
Medicare Part D: $50/mo (starting Jul 2026)
Home delivery via LillyDirect. Check lillydirect.com for current pricing and eligibility.
💉 Injectable GIP / GLP-1 Dual Agonists — Most Effective Class
Mounjaro
Tirzepatide
DiabetesOff-Label Wt.Rx OnlyWeekly Injection
 Subcutaneous injection — weekly
Start 2.5 mg; titrate by 2.5 mg every 4 wks; max 15 mg/wk
Same molecule as Zepbound		 FDA (2022): Type 2 diabetes management
Off-label: Weight loss (very commonly prescribed off-label; same drug, doses, and efficacy as Zepbound)		 14–20%
SURPASS trials (T2D): up to 15% at 15 mg; SURMOUNT data at obesity doses: ~20–22%		 Nausea, diarrhea (may be more prominent than semaglutide), vomiting, constipation, decreased appetite, injection site reactions; same GLP-1 class warnings; Blackbox: thyroid C-cell tumors Personal or family history of MTC or MEN type 2; pregnancy; severe GI disease; pancreatitis (caution); prior hypersensitivity to tirzepatide ~$1,000–1,100 list
No LillyDirect self-pay program. Mounjaro savings card: ~$25/mo copay for eligible insured T2D patients. Off-label weight loss use typically not covered.
Zepbound
Tirzepatide
Weight LossRx OnlyWeekly Injection
 Subcutaneous injection — weekly
Start 2.5 mg; titrate to max 15 mg/wk
Prefilled pen (insurance) or single-dose vials via LillyDirect (self-pay)		 FDA (2023): Chronic weight management — BMI ≥30, or ≥27 with comorbidity
FDA (2024): Moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity — first medication ever approved for OSA		 ~21%
SURMOUNT-1: 20.9% at 15 mg vs 3.1% placebo; ~34% achieved ≥25% loss — greatest of any approved medication		 Nausea, diarrhea, vomiting, constipation, injection site reactions; slightly better tolerability profile than semaglutide reported in head-to-head data; Blackbox: thyroid C-cell tumors Personal or family history of MTC or MEN type 2; pregnancy; severe GI disease; pancreatitis (caution); prior hypersensitivity to tirzepatide; same contraindications as Mounjaro LillyDirect self-pay vials:
$299/mo (2.5 mg)
$399/mo (5 mg)
$449/mo (7.5–15 mg)
~$1,060 list (prefilled pen). Requires valid Rx + refill within 45 days. Also available at Walmart Pharmacy. Check lillydirect.com.
⚠ Important Disclaimer

This table is for educational reference only. It does not constitute medical advice and cannot replace an individualized evaluation with a qualified healthcare provider. Every patient has unique medical history, comorbidities, other medications, and circumstances that affect medication appropriateness. Medication costs, insurance coverage, and availability change frequently — prices shown are approximate US estimates and will vary. Always consult your provider and pharmacist for current, personalized guidance.

📋 Key Concepts

Off-label use means a medication is being used for a purpose not listed in its FDA approval — this is legal and common, but insurance coverage is often denied. REMS (Risk Evaluation and Mitigation Strategy) is an FDA safety program requiring special monitoring for certain high-risk medications. Blackbox warnings are the FDA's strongest safety warnings, printed in a black border on drug labeling. Sources: FDA prescribing information for each medication; American Diabetes Association Standards of Care 2024; Obesity Medicine Association guidelines.

References & sources

  1. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–266.
  2. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332(10):621–628.
  3. Sumithran P, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–1604.
  4. Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23(2):120–133.
  5. Hall KD, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial. Cell Metab. 2019;30(1):67–77.
  6. Ge L, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes: systematic review and network meta-analysis. BMJ. 2020;369:m696.
  7. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. (STEP 1 Trial)
  8. Rubino DM, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021;325(14):1414–1425. (STEP 4 Trial)
  9. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. (SURMOUNT-1 Trial)
  10. Jastreboff AM, et al. Tirzepatide for obesity in adults with type 2 diabetes. N Engl J Med. 2023;389(6):514–526. (SURMOUNT-2 Trial)
  11. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–2232. (SELECT Trial)
  12. Wadden TA, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2020;141(18):1512–1523.
  13. Müller MJ, et al. Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited. Am J Clin Nutr. 2015;102(4):807–819.
  14. Kadowaki T, et al. Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes. Lancet. 2022;400(10351):475–486.
  15. American Diabetes Association. Obesity and weight management for the prevention and treatment of type 2 diabetes. Diabetes Care. 2024;47(Suppl 1):S145–S157.
  16. Eli Lilly and Company. FDA approves Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions. Press release, April 1, 2026. (ATTAIN-1 Phase 3 trial: 72-week weight loss −12.4% vs −0.9% placebo at highest dose, completers.)